hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top

Chair(s)

  • Tania Roskams

    Professor, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.

Speaker(s)

  • Tania Roskams

    Professor, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.
    Topic: Histopathology of liver tumours: all primary and metastatic tumours

  • Swan N. Thung

    Professor of Pathology, Molecular and Cell-Based Medicine; Director of Hepatopathology Division, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
    Topic: HCC Mimickers

  • Vincent Vandecaveye

    Professor at the Catholic University of Leuven; Supervising staff radiologist at the division of abdominal/gynaecological imaging in the department of radiology at the University Hospitals Leuven, Leuven, Belgium.
    Topic: Radiological diagnosis of liver carcinoma

  • Daniela Sia

    Assistant Professor of Medicine, Liver Diseases, Liver Cancer Program, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
    Topic: Understanding liver tumors: new insights into molecular subtypes

  • Cipriani Federica

    Medical Doctor of Department of Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Topic: Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines

  • Jaekyung Cheon

    Assistant Professor of Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
    Topic: Systemic therapy against combined HCC-CCA

Programme

      Time (Belgium)
      Speakers
      Topics
      14:00 - 14:10
      Tania Roskams
      Welcome Speech
      14:10 - 14:30
      Tania Roskams
      Histopathology of liver tumours: all primary and also metastatic tumours
      14:30 - 14:50
      Swan N. Thung
      HCC Mimickers
      14:50 - 15:10
      Vincent Vandecaveye
      Radiological diagnosis of liver carcinoma
      15:10 - 15:30
      Daniela Sia
      Understanding liver tumors: new insights into molecular subtypes
      15:30 - 15:45
      Tania Roskams
      Discussion (Q&A)
      15:45 - 16:05
      Cipriani Federica
      Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines
      16:05 - 16:25
      Jaekyung Cheon
      Systemic therapy against combined HCC-CCA
      16:25 - 16:40
      Tania Roskams
      Discussion (Q&A)

Relevant special issues

Topic: Liver Tumors of Unidentified Primary: are All HCC or HCC-CCA?

https://hrjournal.net/journal/special_detail/1136

Moments

Presentation

  • Tania Roskams, Professor, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.
    Topic: Histopathology of liver tumours: all primary and metastatic tumours
  • Swan N. Thung, Professor of Pathology, Molecular and Cell-Based Medicine; Director of Hepatopathology Division, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
    Topic: HCC Mimickers
  • Vincent Vandecaveye, Professor at the Catholic University of Leuven; Supervising staff radiologist at the division of abdominal/gynaecological imaging in the department of radiology at the University Hospitals Leuven, Leuven, Belgium.
    Topic: Radiological diagnosis of liver carcinoma
  • Daniela Sia, Assistant Professor of Medicine, Liver Diseases, Liver Cancer Program, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
    Topic: Understanding liver tumors: new insights into molecular subtypes
  • Cipriani Federica, Medical Doctor of Department of Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Topic: Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines
  • Jaekyung Cheon, Assistant Professor of Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
    Topic: Systemic therapy against combined HCC-CCA
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties